The American Society for Clinical Investigation
@the-asci.org
The ASCI is a nonprofit honor society of physician-scientists. Founded in 1908, the Society is home to 3,500+ members across academic medicine and industry.
https://the-asci.org
Take action for federal funding of research:
https://www.fundresearch.org/
https://the-asci.org
Take action for federal funding of research:
https://www.fundresearch.org/
Osteoarthritis is the most common joint disease, but there are no approved disease-modifying treatments
ASCI member Martin K. Lotz & team discover histamine H1 receptor inverse agonists improve structure & pain in osteoarthritis mice: www.jci.org/articles/vie...
ASCI member Martin K. Lotz & team discover histamine H1 receptor inverse agonists improve structure & pain in osteoarthritis mice: www.jci.org/articles/vie...
November 10, 2025 at 5:07 PM
Osteoarthritis is the most common joint disease, but there are no approved disease-modifying treatments
ASCI member Martin K. Lotz & team discover histamine H1 receptor inverse agonists improve structure & pain in osteoarthritis mice: www.jci.org/articles/vie...
ASCI member Martin K. Lotz & team discover histamine H1 receptor inverse agonists improve structure & pain in osteoarthritis mice: www.jci.org/articles/vie...
How hypertension promotes bone loss…
ASCI member David G. Harrison & team comprehensively characterize the effect of hypertension on bone properties, finding inflammatory activation and IL-17A-producing T cells as targetable mediators in hypertension-related bone loss: www.jci.org/articles/vie...
ASCI member David G. Harrison & team comprehensively characterize the effect of hypertension on bone properties, finding inflammatory activation and IL-17A-producing T cells as targetable mediators in hypertension-related bone loss: www.jci.org/articles/vie...
October 22, 2025 at 5:38 PM
How hypertension promotes bone loss…
ASCI member David G. Harrison & team comprehensively characterize the effect of hypertension on bone properties, finding inflammatory activation and IL-17A-producing T cells as targetable mediators in hypertension-related bone loss: www.jci.org/articles/vie...
ASCI member David G. Harrison & team comprehensively characterize the effect of hypertension on bone properties, finding inflammatory activation and IL-17A-producing T cells as targetable mediators in hypertension-related bone loss: www.jci.org/articles/vie...